Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Authors

Rajesh Naidu Janapala, The George Washington University School of Medicine and Health Sciences
Jigar Patel, The George Washington University School of Medicine and Health Sciences
Omar Belfaqeeh, The George Washington University School of Medicine and Health Sciences
Abdulla Alhashmi, The George Washington University School of Medicine and Health Sciences
Ali Pourmand, The George Washington University School of Medicine and Health Sciences

Document Type

Letter to the Editor

Publication Date

9-1-2021

Journal

Infectious Diseases and Therapy

Volume

10

Issue

3

DOI

10.1007/s40121-021-00443-5

Keywords

COVID-19; Mortality benefit; Steroids; Tocilizumab

APA Citation

Janapala, R., Patel, J., Belfaqeeh, O., Alhashmi, A., & Pourmand, A. (2021). Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study. Infectious Diseases and Therapy, 10 (3). http://dx.doi.org/10.1007/s40121-021-00443-5